|
ZNF782 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
8.45989944764369E-14 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62458935193399E-12 |
| Stage1-vs-Stage2 |
6.127200E-01 |
| Stage1-vs-Stage3 |
1.782450E-02 |
| Stage1-vs-Stage4 |
1.057780E-02 |
| Stage2-vs-Stage3 |
4.309800E-02 |
| Stage2-vs-Stage4 |
1.510120E-02 |
| Stage3-vs-Stage4 |
4.893000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62436730732907E-12 |
| Normal-vs-AfricanAmerican |
2.53080001400008E-09 |
| Normal-vs-Asian |
1.62736490949555E-12 |
| Caucasian-vs-AfricanAmerican |
3.561800E-01 |
| Caucasian-vs-Asian |
2.091800E-01 |
| AfricanAmerican-vs-Asian |
9.949800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62436730732907E-12 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
6.487600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
3.64409999953352E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.242600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.462800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.356600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.403800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.514200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.364800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.16509999999959E-05 |
| Classical-VS-Follicular |
4.495700E-03 |
| Classical-VS-Other |
9.441400E-01 |
| Classical-VS-Normal |
1.11022302462516E-16 |
| Tall-VS-Follicular |
7.14669999846151E-08 |
| Tall-VS-Other |
1.700600E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
3.944000E-01 |
| Follicular-VS-Normal |
2.53763676738572E-12 |
| Other-VS-Normal |
8.01129999999928E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.62436730732907E-12 |
| N0-vs-N1 |
7.406300E-02 |
|
|
